Economic and humanistic outcomes among patients receiving percutaneous coronary intervention in a tertiary care hospital of South India

Pradeep M. Muragundi, Anil M. Tumkur, K. Ranjan Shetty, Nayanabhirama Udupa, Anantha N. Naik

Research output: Contribution to journalArticle

Abstract

The objective of the study is to evaluate the humanistic outcomes and cost outcomes among patients receiving percutaneous coronary intervention in a tertiary care setup. The quality of life studies data was collected from the patients at Kasturba Hospital, Manipal, India, a tertiary care hospital. The instrument to measure health status was EQ-5D-5L involving English and Kannada version. The pharmacoeconomic data was computed from data record sheets and data pertaining to socio-demographic information along with cost of treatment and clinical outcomes. The model of the study was prospective and observational, evaluation of bare metal stents and drug eluting stents used during percutaneous coronary intervention for the period of nine months. Data pertaining to cost outcomes of the subjects included in the study are derived from case record files of outpatients and inpatients of Cardiology Department. The mean age of patients for bare metal stent group was 57.8 ± 9.3 years and for drug eluting stent group was 60.7 ±10.1 years. Repeated measures ANOVA of utility scores and VAS scores showed significant variation in both groups over a period of nine month follow-up. Mann-Whitney test significance was found to be <0.001 for total cost involved in percutaneous coronary intervention among both the groups. The study was able to provide insight in to the benefit received by the patients with drug eluting stents in terms of humanistic outcomes and the cost to be paid for the same at a tertiary care setup in India

Original languageEnglish
Article number34
Pages (from-to)177-182
Number of pages6
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume41
Issue number2
Publication statusPublished - 01-11-2016

Fingerprint

Percutaneous Coronary Intervention
Tertiary Healthcare
Tertiary Care Centers
India
Economics
Drug-Eluting Stents
Costs and Cost Analysis
Stents
Metals
Pharmaceutical Economics
Cardiology
Health Status
Observational Studies
Inpatients
Analysis of Variance
Outpatients
Quality of Life
Demography
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{34c9930f844e4c3ea197a15465f871d5,
title = "Economic and humanistic outcomes among patients receiving percutaneous coronary intervention in a tertiary care hospital of South India",
abstract = "The objective of the study is to evaluate the humanistic outcomes and cost outcomes among patients receiving percutaneous coronary intervention in a tertiary care setup. The quality of life studies data was collected from the patients at Kasturba Hospital, Manipal, India, a tertiary care hospital. The instrument to measure health status was EQ-5D-5L involving English and Kannada version. The pharmacoeconomic data was computed from data record sheets and data pertaining to socio-demographic information along with cost of treatment and clinical outcomes. The model of the study was prospective and observational, evaluation of bare metal stents and drug eluting stents used during percutaneous coronary intervention for the period of nine months. Data pertaining to cost outcomes of the subjects included in the study are derived from case record files of outpatients and inpatients of Cardiology Department. The mean age of patients for bare metal stent group was 57.8 ± 9.3 years and for drug eluting stent group was 60.7 ±10.1 years. Repeated measures ANOVA of utility scores and VAS scores showed significant variation in both groups over a period of nine month follow-up. Mann-Whitney test significance was found to be <0.001 for total cost involved in percutaneous coronary intervention among both the groups. The study was able to provide insight in to the benefit received by the patients with drug eluting stents in terms of humanistic outcomes and the cost to be paid for the same at a tertiary care setup in India",
author = "Muragundi, {Pradeep M.} and Tumkur, {Anil M.} and {Ranjan Shetty}, K. and Nayanabhirama Udupa and Naik, {Anantha N.}",
year = "2016",
month = "11",
day = "1",
language = "English",
volume = "41",
pages = "177--182",
journal = "International Journal of Pharmaceutical Sciences Review and Research",
issn = "0976-044X",
publisher = "Global Research Online",
number = "2",

}

TY - JOUR

T1 - Economic and humanistic outcomes among patients receiving percutaneous coronary intervention in a tertiary care hospital of South India

AU - Muragundi, Pradeep M.

AU - Tumkur, Anil M.

AU - Ranjan Shetty, K.

AU - Udupa, Nayanabhirama

AU - Naik, Anantha N.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The objective of the study is to evaluate the humanistic outcomes and cost outcomes among patients receiving percutaneous coronary intervention in a tertiary care setup. The quality of life studies data was collected from the patients at Kasturba Hospital, Manipal, India, a tertiary care hospital. The instrument to measure health status was EQ-5D-5L involving English and Kannada version. The pharmacoeconomic data was computed from data record sheets and data pertaining to socio-demographic information along with cost of treatment and clinical outcomes. The model of the study was prospective and observational, evaluation of bare metal stents and drug eluting stents used during percutaneous coronary intervention for the period of nine months. Data pertaining to cost outcomes of the subjects included in the study are derived from case record files of outpatients and inpatients of Cardiology Department. The mean age of patients for bare metal stent group was 57.8 ± 9.3 years and for drug eluting stent group was 60.7 ±10.1 years. Repeated measures ANOVA of utility scores and VAS scores showed significant variation in both groups over a period of nine month follow-up. Mann-Whitney test significance was found to be <0.001 for total cost involved in percutaneous coronary intervention among both the groups. The study was able to provide insight in to the benefit received by the patients with drug eluting stents in terms of humanistic outcomes and the cost to be paid for the same at a tertiary care setup in India

AB - The objective of the study is to evaluate the humanistic outcomes and cost outcomes among patients receiving percutaneous coronary intervention in a tertiary care setup. The quality of life studies data was collected from the patients at Kasturba Hospital, Manipal, India, a tertiary care hospital. The instrument to measure health status was EQ-5D-5L involving English and Kannada version. The pharmacoeconomic data was computed from data record sheets and data pertaining to socio-demographic information along with cost of treatment and clinical outcomes. The model of the study was prospective and observational, evaluation of bare metal stents and drug eluting stents used during percutaneous coronary intervention for the period of nine months. Data pertaining to cost outcomes of the subjects included in the study are derived from case record files of outpatients and inpatients of Cardiology Department. The mean age of patients for bare metal stent group was 57.8 ± 9.3 years and for drug eluting stent group was 60.7 ±10.1 years. Repeated measures ANOVA of utility scores and VAS scores showed significant variation in both groups over a period of nine month follow-up. Mann-Whitney test significance was found to be <0.001 for total cost involved in percutaneous coronary intervention among both the groups. The study was able to provide insight in to the benefit received by the patients with drug eluting stents in terms of humanistic outcomes and the cost to be paid for the same at a tertiary care setup in India

UR - http://www.scopus.com/inward/record.url?scp=85018209404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018209404&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 177

EP - 182

JO - International Journal of Pharmaceutical Sciences Review and Research

JF - International Journal of Pharmaceutical Sciences Review and Research

SN - 0976-044X

IS - 2

M1 - 34

ER -